Effect of calcineurin inhibitor on post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with liver transplantation: a propensitymatched cohort study
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: A calcineurin inhibitor may alter pancreatic function and inflammatory reaction. This study aimed to determine the possible pharmacologic effect of the calcineurin inhibitor, tacrolimus, on pancreatic function, and to determine its preventive effect on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in liver transplantation (LT) patients. Methods: The serum amylase and lipase values before and after LT were compared. The frequency of post-ERCP pancreatitis was compared between non-LT and LT patients, using propensity score matching method. Results: Median serum amylase values (normal range, 19 to 86 U/L) were 49.0 U/L (38.0 to 68.0) before LT and 27.0 U/L (19.3 to 36.8) after LT, and median serum lipase values (normal range, 7 to 59 U/L) were 40.0 U/L (26.5 to 54.0) before LT and 10.5 U/L (6.0 to 21.0) after LT. Both serum amylase and lipase values significantly decreased after LT (p < 0.001), and to a level comparable to chronic pancreatitis. There was a marginal significant difference between the non-LT and LT groups before the propensity score matching with respect to frequency of post-ERCP pancreatitis (16 [3.2%] in non-LT group vs. 2 [0.9%] in LT group, p = 0.069). After propensity score matching, a marginal significant difference still existed with respect to frequency of post-ERCP pancreatitis (7 [4.8%] in non-LT group vs. 1 [0.7%] in LT group, p = 0.067). Conclusions: The immunosuppression with calcineurin inhibitor may reduce not only the pancreatic enzyme dynamics but also inciting inflammatory event including post-ERCP pancreatitis.
Abstract
Background/Aims: A calcineurin inhibitor may alter pancreatic function and inflammatory reaction. This study aimed to determine the possible pharmacologic effect of the calcineurin inhibitor, tacrolimus, on pancreatic function, and to determine its preventive effect on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in liver transplantation (LT) patients. Methods: The serum amylase and lipase values before and after LT were compared. The frequency of post-ERCP pancreatitis was compared between non-LT and LT patients, using propensity score matching method. Results: Median serum amylase values (normal range, 19 to 86 U/L) were 49.0 U/L (38.0 to 68.0) before LT and 27.0 U/L (19.3 to 36.8) after LT, and median serum lipase values (normal range, 7 to 59 U/L) were 40.0 U/L (26.5 to 54.0) before LT and 10.5 U/L (6.0 to 21.0) after LT. Both serum amylase and lipase values significantly decreased after LT (p < 0.001), and to a level comparable to chronic pancreatitis. There was a marginal significant difference between the non-LT and LT groups before the propensity score matching with respect to frequency of post-ERCP pancreatitis (16 [3.2%] in non-LT group vs. 2 [0.9%] in LT group, p = 0.069). After propensity score matching, a marginal significant difference still existed with respect to frequency of post-ERCP pancreatitis (7 [4.8%] in non-LT group vs. 1 [0.7%] in LT group, p = 0.067). Conclusions: The immunosuppression with calcineurin inhibitor may reduce not only the pancreatic enzyme dynamics but also inciting inflammatory event including post-ERCP pancreatitis.
참고문헌 (24)
- Freeman ML, "Prevention of post-ERCP pancreatitis : a comprehensive review", Gastrointest Endosc, 59, pp.845~864 (2004)
- Elmunzer BJ, "A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis", N Engl J Med, 366, pp.1414~1422 (2012)
- Thiruvengadam NR, "Rectal indomethacin reduces pancreatitis in high-and low-risk patients undergoing endoscopic retrograde cholangiopancreatography", Gastroenterology, 151, pp.288~297 (2016)
- Luo H, "Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography : a multicentre, single-blinded, randomised controlled trial", Lancet, 387, pp.2293~2301 (2016)
- Balderramo D, "Complications after ERCP in liver transplant recipients", Gastrointest Endosc, 74, pp.285~294 (2011)
- Law R, "Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation : a retrospective analysis", Liver Transpl, 19, pp.1354~1360 (2013)
- Ambrus RB, "Post-endoscopic retrograde cholangiopancreaticography complications in liver transplanted patients, a single-center experience", Scand J Surg, 104, pp.86~91 (2015)
- Sanna C, "Endoscopic retrograde cholangiopancreatography in patients with biliary complications after orthotopic liver transplantation : outcomes and complications", Transplant Proc, 41, pp.1319~1321 (2009)
- Shah AU, "Protease activation during in vivo pancreatitis is dependent on calcineurin activation", Am J Physiol Gastrointest Liver Physiol, 297, pp.G967~G973 (2009)
- Jin S, "Exposure to radioc ontrast agents induces pancreatic inflammation by activation of nuclear factor-κB, calcium signaling, and calcineurin", Gastroenterology, 149, pp.753~764 (2015)
- Sofuni A, "Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent", Clin Gastroenterol Hepatol, 5, pp.1339~1346 (2007)
- Mazaki T, "Prophylactic pancreatic stent placement and post-ERCP pancreatitis : an updated meta-analysis", J Gastroenterol, 49, pp.343~355 (2014)
- Cheon YK, "Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification", Gastrointest Endosc, 65, pp.385~393 (2007)
- Kwon CI, "Can we detect chronic pancreatitis with low serum pancreatic enzyme levels", Pancreas, 45, pp.1184~1188 (2016)
- 오형철, "Low Serum Pancreatic Amylase and Lipase Values Are Simple and Useful Predictors to Diagnose Chronic Pancreatitis", Gut and Liver, 11(6), pp.878~883 (2017), 거트앤리버 소화기연관학회협의회
- Cotton PB, "Endoscopic sphincterotomy complications and their management : an attempt at consensus", Gastrointest Endosc, 37, pp.383~393 (1991)
- Perkins SM, "The use of propensity scores in pharmacoepidemiologic research", Pharmacoepidemiol Drug Saf, 9, pp.93~101 (2000)
- Brookhart MA, "Variable selection for propensity score models", Am J Epidemiol, 163, pp.1149~1156 (2006)
- Austin PC, "A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003", Stat Med, 27, pp.2037~2049 (2008)
- Levenick JM, "Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients", Gastroenterology, 150, pp.911~917 (2016)
- Sherman S, "Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis : a randomized, prospective, multicenter study", Gastrointest Endosc, 58, pp.23~29 (2003)
- Manolakopoulos S, "Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis : a multicenter randomized controlled trial", Gastrointest Endosc, 55, pp.470~475 (2002)
- Tanzi MG, "Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients", Clin Transplant, 30, pp.901~911 (2016)
- Fogel EL, "Rectal indomethacin dose escalation for prevention of post-ERCP pancreatitis in high-risk patients: preliminary report of a multicenter randomized trial (RIDE Trial): Category Award (Biliary", Pancreas) 1, 2018, pp.113, S1~